A Survey of Canadian Gastroenterologists about the Use of Methotrexate in Patients with Crohn’s Disease

BACKGROUND: Methotrexate (MTX) is effective in remission induction and maintenance in steroid-dependent Crohn's disease (CD), but is often considered to be a second-line immunosuppressive agent, to be used in cases of failure or intolerance to azathioprine (AZA) or 6-mercaptopurine (6-MP). This...

Full description

Saved in:
Bibliographic Details
Main Authors: Nilesh Chande, Terry Ponich, James Gregor
Format: Article
Language:English
Published: Wiley 2005-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2005/382379
Tags: Add Tag
No Tags, Be the first to tag this record!